Ensysce Biosciences, Inc. · NASDAQ:ENSC
Perceptive Advisors LLC reported a 5.30% stake in Ensysce Biosciences, Inc. (Schedule 13G/A)
Event Mar 31, 2025 · Filed Apr 3, 2025
Perceptive Advisors LLC reported a 5.30% stake in Ensysce Biosciences, Inc., 86,666 shares, as a passive investor on Mar 31, 2025. Filed Apr 3, 2025 (Schedule 13G/A).
- Stake
- 5.30%
- Shares
- 86,666
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Perceptive Advisors LLC | 5.30% | 86,666 |
| Joseph Edelman | 5.30% | 86,666 |
| Perceptive Life Sciences Master Fund, Ltd. | 5.30% | 86,666 |
Source
Related
- Ensysce Biosciences, Inc.
- Perceptive Advisors LLC
- Ensysce Biosciences, Inc. shareholders
- Schedule 13G/A · Perceptive Advisors LLC · May 15, 2025
- Schedule 13G/A · Perceptive Advisors LLC · Feb 14, 2025
- Form 4 · Bob Gene Gower · Aug 18, 2026
- Schedule 13D/A · Bob Gene Gower · Aug 18, 2026
- Schedule 13G/A · Adage Capital Management, L.P. · Aug 12, 2025
- Schedule 13G · Adage Capital Management, L.P. · May 12, 2025